Trial Profile
Effect of a Sulforaphane-Yielding Encapsulated Product compared with Placebo on Arterial Stiffness and other Biochemical Markers in Type 2 Diabetics aged 18-45 years.
Status:
Not yet recruiting
Phase of Trial:
Phase I
Latest Information Update: 23 Jun 2016
Price :
$35
*
At a glance
- Drugs Sulforafan (Primary)
- Indications Diabetic complications
- Focus Biomarker; Pharmacodynamics
- Acronyms EASY DIAB 2
- 10 Jul 2012 New trial record